EyePoint Pharmaceuticals announced the appointment of Ron Honig, Esq., as Senior Vice President, general counsel, and company secretary, effective immediately. In this new role, Mr. Honig will the oversee the company’s legal activities, including the legal aspects of licensing, compliance, strategic transactions, and business development.
Mr. Honig brings to EyePoint more than 25 years of legal experience in the medical device, biotechnology, contract manufacturing, and legal services industries. As lead in-house counsel to publicly-traded companies and private equity portfolio companies in the global healthcare industry, Mr. Honig has managed legal and compliance functions and has had responsibility for a wide variety of business transactions.
“Ron brings substantial expertise in complex and corporate legal matters in the healthcare industry, with recent experience in commercial-stage companies,” Nancy Lurker, President and Chief Executive Officer of EyePoint Pharmaceuticals, said in a company news release. “As EyePoint transforms into a commercial company and we expand our ophthalmology pipeline, Ron’s legal and business acumen, coupled with his strong leadership skills, will be highly valued and we welcome him to our growing team.”
“I am thrilled to join such a dynamic team at EyePoint at a critical juncture for the company as it prepares to launch two ophthalmic products in the first half of calendar 2019 and seeks to expand its product portfolio,” said Mr. Honig.
Mr. Honig brings to EyePoint a breadth of knowledge in corporate governance, securities law compliance, and mergers and acquisitions garnered over a 25-year tenure. Most recently, Mr. Honig served as Vice President, Global Legal Affairs for Novanta Inc., a publicly-traded company that develops and manufactures technology solutions for medical device and advanced industrial equipment makers worldwide. Prior to Novanta, he was the Senior Vice President, general counsel & company secretary of Lake Region Medical, a privately-held medical device and medical component manufacturer, where he was responsible for all legal, intellectual property and environmental, health and safety functions worldwide. In addition, Mr. Honig served as Vice President, Group Legal Affairs and Company Secretary for Gyrus ACMI, a publicly-traded medical device manufacturer focused on urological and gynecological endoscopes, digital visualization and endoscopic treatment and delivery modalities.
In addition to in-house legal experience, Mr. Honig has served as a corporate attorney for several law firms, including Mintz Levin Cohn Ferris Glovsky and Popeo in Boston, Massachusetts. He earned his Juris Doctor degree from Boston University School of Law, where he served as Editor-In-Chief of the Boston University Law Review. He earned a Bachelor of Science in finance from the Wharton School and a Bachelor of Applied Science in systems engineering from the School of Engineering at the University of Pennsylvania.